The risk of cardiovascular events associated with inhaled long-acting beta-2-adrenoreceptor agonists in patients with chronic obstructive pulmonary disease

被引：1
|
作者：
Ogale, Sarika S. [1 ]
Lee, Todd A. [1 ]
Sullivan, Sean D. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
CHEST | 2006年 / 130卷 / 04期
关键词：
D O I：
10.1378/chest.130.4_MeetingAbstracts.121S-d
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：121S / 122S
页数：2
相关论文
共 50 条
  • [21] Long-acting β2 agonists in the management of stable chronic obstructive pulmonary disease
    Cazzola, M
    Donner, CF
    DRUGS, 2000, 60 (02) : 307 - 320
  • [22] Once-daily long-acting beta 2-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease
    Sliwka, Agnieszka
    Jankowski, Milosz
    Gross-Sondej, Iwona
    Storman, Monika
    Nowobilski, Roman
    Bala, Malgorzata M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [23] Management of Chronic Obstructive Pulmonary Disease: Insights into Patient Profile - Use of Inhaled Corticosteroids/Long-Acting β2-Agonists or Long-Acting β2-Agonists/Long-acting Muscarinic Antagonists
    Kishore, Nevin
    Moitra, Saibal
    Sircar, Mrinal
    INDIAN JOURNAL OF RESPIRATORY CARE, 2020, 9 (02) : 162 - 170
  • [24] Survival with Tiotropium Compared to Long-Acting Beta-2-Agonists in Chronic Obstructive Pulmonary Disease
    Gershon, Andrea S.
    Wang, Li
    To, Teresa
    Luo, Jin
    Upshur, Ross E. G.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2008, 5 (04) : 229 - 234
  • [25] A benefit-risk assessment of inhaled long-acting β2-agonists in the management of obstructive pulmonary disease
    Sovani, MP
    Whale, CI
    Tattersfield, AE
    DRUG SAFETY, 2004, 27 (10) : 689 - 715
  • [26] A Benefit-Risk Assessment of Inhaled Long-Acting β2-Agonists in the Management of Obstructive Pulmonary Disease
    Milind P. Sovani
    Christopher I. Whale
    Anne. E. Tattersfield
    Drug Safety, 2004, 27 : 689 - 715
  • [27] Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease
    Busch-Petersen, Jakob
    Laine, Dramane I.
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (13) : 1623 - 1634
  • [28] Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease
    Chong, Jimmy
    Karner, Charlotta
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
  • [29] Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta2-agonists formulations in chronic obstructive pulmonary disease
    Pirina, Pietro
    Barbaro, Maria Pia Foschino
    Paleari, Davide
    Spanevello, Antonio
    RESPIRATORY MEDICINE, 2018, 143 : 74 - 81
  • [30] Effects of Inhaled Corticosteroids in Monotherapy or Combined with Long-Acting β2-Agonists on Mortality Among Patients with Chronic Obstructive Pulmonary Disease
    Cyr, Marie-Christyne
    Beauchesne, Marie-France
    Lemiere, Catherine
    Aaron, Shawn D.
    Blais, Lucie
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (04) : 613 - 622
12345